Funder
Ferring Pharmaceuticals, Inc
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference53 articles.
1. Guh AY, Kutty PK. Clostridioides difficile infection. Ann Intern Med. 2018;169(7):itc49–itc64.
2. Park SO, Yeo I. Trends in Clostridioides difficile prevalence, mortality, severity, and age composition during 2003–2014, the national inpatient sample database in the US. Ann Med. 2022;54(1):1851–8.
3. Centers for Disease Control and Prevention. Emerging infections program, healthcare associated infections—community interface surveillance report, Clostridioides difficile infection (CDI), 2019 [PDF – 10 Pages]. Access date August 11, 2022. [Available from: https://www.cdc.gov/hai/eip/pdf/cdiff/2019-CDI-Report-H.pdf].
4. Johnson S, Lavergne V, Skinner AM, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021;73(5):e1029–44. https://doi.org/10.1093/cid/ciab549.
5. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–34.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献